Immunology and Microbiology
Airway
85%
Amplicon Sequencing
8%
Antimicrobial Resistance
17%
Asthma
25%
Bacterial Cell
11%
Bacterial Load
11%
Bronchoalveolar Lavage Fluid
5%
Clinical Decision Making
5%
Cytokine
6%
Dynamics
5%
Feces microflora
20%
Forced Expiratory Volume
7%
Freeze Thawing
5%
Gene Sequence
6%
Germfree Mouse
5%
Gut Microbiome
31%
Haemophilus influenzae
20%
Horizontal Gene Transfer
5%
Human Microbiome
11%
Immunity
6%
Infectious Agent
44%
Innate Immune System
6%
Interleukin 8
10%
Intestine Flora
39%
Lower Respiratory Tract
8%
Metabolic Regulation
5%
Metabolite
10%
Metagenomics
5%
Microbial Diversity
10%
Microbiology
29%
Microbiome
79%
Microflora
100%
Microorganism
17%
Middle Ear
6%
Nontuberculous mycobacteria
5%
Normal Human
5%
Oropharynx
6%
Otitis Media
5%
Peritonitis
6%
Prevalence
12%
Pseudomonas aeruginosa
36%
Pyrosequencing
9%
Real-Time Polymerase Chain Reaction
24%
Restriction Fragment Length Polymorphism
6%
RNA Gene
9%
Severe Asthma
10%
Sputum
40%
Streptococcus
5%
Taxon
21%
Whole Genome Sequencing
5%
Medicine and Dentistry
Aged Care
6%
Antibiotic Resistance
10%
Antibiotic Therapy
15%
Antibiotics
6%
Antiinfective Agent
6%
Antimicrobial Therapy
6%
Ascites
6%
Asthma
13%
Asthma Exacerbation
7%
Azithromycin
10%
Body Mass Index
6%
Bronchiectasis
24%
Chronic Lung Disease
6%
Clinical Trial
10%
Cystic Fibrosis
62%
Diagnosis
5%
Diseases
14%
Dysbiosis
7%
Erythromycin
9%
Fecal Microbiota Transplantation
6%
Glycemic Control
7%
Gut
16%
Gut Microbiome
28%
Gut Microbiota
21%
Haemophilus influenzae
5%
Infection
29%
Inflammasome
6%
Interleukin 1beta Converting Enzyme
6%
Low Drug Dose
5%
Lung
28%
Lung Infection
5%
Macrolide
14%
Microbiome
52%
Obesity
9%
Pathogen
24%
Patient Care
6%
Patient with Cystic Fibrosis
8%
Placebo
10%
Prevalence
7%
Pseudomonas aeruginosa
14%
Randomized Controlled Trial
24%
Real-Time Polymerase Chain Reaction
6%
Respiratory Disease
17%
Respiratory Tract Infection
15%
Respiratory Tract Inflammation
6%
Restriction Fragment Length Polymorphism
9%
RNA 16S
7%
Silo-Filler's Disease
12%
Sputum
19%
Supplementation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Almond
10%
Antibiotic Therapy
8%
Antibiotics
9%
Antiinfective Agent
7%
Antimicrobial Therapy
7%
Azithromycin
6%
Bronchiectasis
10%
Clinical Trial
6%
Cystic Fibrosis
47%
Diseases
8%
Erythromycin
9%
Feces microflora
13%
Infection
16%
Infectious Agent
5%
Intestine Flora
7%
Lung Disease
6%
Lung Infection
8%
Macrolide
13%
Microbiome
21%
Microflora
28%
Microorganism
5%
Placebo
5%
Pseudomonas aeruginosa
21%
Randomized Controlled Trial
6%
Respiratory Tract Disease
9%
Respiratory Tract Infection
6%